Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) will likely be posting its quarterly earnings results before the market opens on Friday, February 28th. Analysts expect Rapid Micro Biosystems to post earnings of ($0.22) per share and revenue of $8.20 million for the quarter. Individual that wish to listen to the company's earnings conference call can do so using this link.
Rapid Micro Biosystems Stock Up 22.1 %
Shares of Rapid Micro Biosystems stock traded up $0.60 during trading on Thursday, hitting $3.31. 714,920 shares of the company were exchanged, compared to its average volume of 430,316. Rapid Micro Biosystems has a fifty-two week low of $0.58 and a fifty-two week high of $4.04. The firm has a 50 day moving average price of $1.87 and a 200 day moving average price of $1.27. The stock has a market capitalization of $142.44 million, a price-to-earnings ratio of -2.96 and a beta of 1.25.
Wall Street Analyst Weigh In
Separately, KeyCorp began coverage on Rapid Micro Biosystems in a research note on Wednesday, February 12th. They set an "overweight" rating and a $8.00 price objective on the stock.
Read Our Latest Report on RPID
About Rapid Micro Biosystems
(
Get Free Report)
Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
Read More

Before you consider Rapid Micro Biosystems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rapid Micro Biosystems wasn't on the list.
While Rapid Micro Biosystems currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.